ArticleISRN obstetrics and gynecology2011

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.

Ana M Solares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.